What is Therapeutic Misrepresentation?

• A. Concealing adverse effects from participants
• B. Falsely labeling a trial as a different study
• C. IMPLYING that a drug or treatment is efficacious knowing that it has not conclusively been proven
• D. Believing that all research has no risks

Answer: (C)

Therapeutic misrepresentation is about communicating a treatment’s benefits as certain or proven when the evidence doesn’t actually support that conclusion. It happens when a researcher or clinician implies or states that a drug or therapy is efficacious even though the data are inconclusive or insufficient, thereby shaping a participant’s decision to enroll or to try the treatment based on an inflated sense of benefit. This breaches informed consent and trust because participants are led to accept risks with the expectation of proven benefit.

Why this is the best fit: it directly captures the unethical act of conveying therapeutic benefit without solid proof, which is the core issue in therapeutic misrepresentation. The other scenarios involve different ethical problems—concealing adverse effects is about withholding information about harms, mislabeling a trial about the study’s identity is deception about the trial itself, and the notion that all research has no risks is simply false and not a description of misrepresentation of therapeutic benefit.